...
首页> 外文期刊>American Journal of Cancer Research >MicroRNA-195 suppresses colorectal cancer cells proliferation via targeting FGF2 and regulating Wnt/β-catenin pathway
【24h】

MicroRNA-195 suppresses colorectal cancer cells proliferation via targeting FGF2 and regulating Wnt/β-catenin pathway

机译:MicroRNA-195通过靶向FGF2和调节Wnt /β-catenin途径抑制结直肠癌细胞的增殖

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Colorectal cancer (CRC) is a prevalent cancer with high mortality worldwide. This study was aimed to explore the functional effects of microRNA-195 (miR-195) on CRC cells and the underling mechanism involved. quantitative PCR (qPCR) was performed to monitor the expression of miR-195 in CRC tissues and cell lines. SW480 and SW620 cells were transfected with either miR-195 mimic or antisense oligonucleotides (ASO) of miR-195. Then cell viability, cell cycle and the expressions of CyclinB1, CyclinD1 and Cyclin-Dependent Kinase 2 (CDK2) were respectively detected by 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyltetrazolium bromide (MTT), flow cytometry, qPCR and Western blot. A target of miR-195 was predicted and verified in vitro by using TargetScan and microRNA database, Dual-Luciferase reporter assay, qPCR and Western blot. Further, the functions of the target on cell viability and cell cycle were detected by transfection with its expression vector. Moreover, the expressions of Wnt/β-catenin pathway proteins were detected by qPCR and Western blot. Results show that MiR-195 was decreased during CRC, and miR-195 overexpression inhibited cell viability, arrested cells in G2/M phase, and down-regulated CyclinB1, CyclinD1 and CDK2 (P < 0.05 or P < 0.01). Fibroblast growth factor 2 (FGF2) was a direct target of miR-195 and alleviated the inhibitive effects of miR-195 on cell viability and cell cycle progression (P < 0.05 or P < 0.01). Further, miR-195 specifically regulated Wnt/β-catenin pathway proteins (P < 0.01). All these findings suggest that miR-195 suppressed CRC cells proliferation via targeting FGF2 and blocking Wnt/β-catenin pathway.
机译:大肠癌(CRC)是一种普遍存在的癌症,在世界范围内具有很高的死亡率。这项研究的目的是探讨microRNA-195(miR-195)对CRC细胞的功能作用及其所涉及的潜在机制。进行定量PCR(qPCR)来监测miR-195在CRC组织和细胞系中的表达。用miR-195的miR-195模拟或反义寡核苷酸(ASO)转染SW480和SW620细胞。然后分别用3-(4,5-二甲基-2-噻唑基)-2、5-二苯基四唑溴化物(MTT)检测细胞活力,细胞周期以及CyclinB1,CyclinD1和细胞周期蛋白依赖性激酶2(CDK2)的表达,流式细胞仪,qPCR和Western印迹。通过使用TargetScan和microRNA数据库,双重荧光素酶报道基因分析,qPCR和Western blot预测并验证了miR-195的靶标。此外,通过用其表达载体转染来检测靶标对细胞活力和细胞周期的功能。此外,通过qPCR和Western blot检测Wnt /β-catenin途径蛋白的表达。结果显示,在CRC期间,MiR-195降低,而miR-195的过表达抑制细胞活力,使细胞停滞在G2 / M期并下调CyclinB1,CyclinD1和CDK2(P <0.05或P <0.01)。成纤维细胞生长因子2(FGF2)是miR-195的直接靶标,并减轻了miR-195对细胞活力和细胞周期进程的抑制作用(P <0.05或P <0.01)。此外,miR-195特异性调节Wnt /β-catenin途径蛋白(P <0.01)。所有这些发现表明,miR-195通过靶向FGF2和阻断Wnt /β-catenin途径抑制CRC细胞增殖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号